IMS Health Inc. (RX:US) surged 23 percent to $20.73 for the biggest gain in the S&P 500. The provider of prescription data to drugmakers and analysts, agreed to sell itself to investment funds managed by TPG Capital and the CPP Investment Board for $22 a share, or about $5.2 billion.